SMC021 Oral calcitonin
SMC021A2303
Phase 3 small_molecule completed
Quick answer
SMC021 Oral calcitonin for Osteoporosis is a Phase 3 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nordic Bioscience A/S
- Indication
- Osteoporosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed